Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Comment by Straniuson Jun 16, 2017 10:03am
207 Views
Post# 26370462

RE:LDS in the market doing small US side only Private Placement

RE:LDS in the market doing small US side only Private PlacementI received some colour from Management on this US side private placement. Management indicated to me that the reason for this US side raise was to accommodate a group of US investors that were precluded from participating in the Canaccord PP that closed on May 31 due to administrative delays related to US investors.

There is nothing nefarious about this raise is my takeaway and they are not shopping this deal to new investors. All participants in this US side raise were already known before this deal was launched and, in fact, this financing is closing today, June 16. We should be back to news flow next week and management has provided assurance to me that the COO will be issued this month (after a small technical glitch with laying the floor in the Adelanto facility) with calibration of equipment to follow immediately thereafter. One of the key pieces of manufacturing equipment has already undergone calibration over the last two weeks.

~S

Stranius wrote: LDS (quietly) disclosed through it's US side filing on EDGAR that it is in the market doing a small private placement for US investors only. Pricing is the same as the Canaccord PP that closed on May 31, 2017.


Bullboard Posts